Injective (INJ) price has recorded a surge of nearly 9% today after the project announced a major regulatory milestone in the US. According to the latest development, its affiliate Injective Institutional is now registered with the US Securities and Exchange Commission (SEC) as a transfer agent. This breakthrough has helped fuel the recent rally in
The post INJ Price Rallies 9% as Injective Receives Transfer Agent Registration from US SEC appeared first on CoinGape.
Matthew Ruthven is a crypto journalist and blockchain strategist with a passion for exploring the intersection of technology, finance, and decentralized governance. With a background in software development and digital economics, he brings a technical yet accessible approach to analyzing the latest trends in cryptocurrency and Web3 innovation.